Cargando…
EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas
Hypermethylation of tumor suppressor genes is one of the hallmarks in the progression of brain tumors. Our objectives were to analyze the presence of the hypermethylation of EPB41L3, RASSF2 and TSP-1 genes in 132 diffuse gliomas (astrocytic and oligodendroglial tumors) and in 10 cases of normal brai...
Autores principales: | Perez-Janices, Noemi, Blanco-Luquin, Idoia, Tuñón, Maria Teresa, Barba-Ramos, Edurne, Ibáñez, Berta, Zazpe-Cenoz, Idoya, Martinez-Aguillo, Maria Teresa, Hernandez, Berta, Martínez-Lopez, Enrique, Fernández, Agustin F., Mercado, Maria Roasario, Cabada, Teresa, Escors, David, Megias, Diego, Guerrero-Setas, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381601/ https://www.ncbi.nlm.nih.gov/pubmed/25621889 |
Ejemplares similares
-
Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis
por: Perez-Janices, Noemi, et al.
Publicado: (2015) -
Promoter Methylation of RASSF1A Associates to Adult Secondary Glioblastomas and Pediatric Glioblastomas
por: Muñoz, Jorge, et al.
Publicado: (2012) -
Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?
por: Escors, David, et al.
Publicado: (2013) -
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017) -
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice
por: Liechtenstein, Therese, et al.
Publicado: (2014)